LANXESS successfully places EUR 500 million benchmark bond

Cologne

The specialty chemicals company LANXESS has successfully placed a 6-year-tenor euro benchmark bond with a coupon of 0.0 percent in the European capital market. LANXESS will use the funds to finance the planned acquisition of the microbial control business of US-based chemical company IFF.

The new bond is listed on the Luxembourg Stock Exchange in denominations of EUR 1,000.

“We have secured a first step of financing already quickly after the announcement of the acquisition of IFF Microbial Control and are happy about the very receptive reaction of the capital market to our offering,” said LANXESS Chief Financial Officer Michael Pontzen.

LANXESS' issuer ratings are currently Baa2 (Moody’s), BBB (Standard & Poor’s) and BBB+ (Scope). A bank consortium of active joint bookrunners comprising Citi, Société Générale and Unicredit was mandated to place the bond.

Information for editors:
All global LANXESS news releases and their accompanying photos can be found at http://press.lanxess.com.
Recent photos of the Board of Management and other LANXESS image material are available at http://photos.lanxess.com.

 

MORE ABOUT THIS TOPIC

PRESS RELEASE
Logo IFAT Munich

Ion exchange resins for persuasive answers to a wide range of challenges

April 30, 2024
PRESS RELEASE
Scopeblue Lewatit keyvisual - Employee with Lewatit in test tube on which a plant is growing

LANXESS: New sustainable ion exchange resin for water softening

April 29, 2024
PRESS RELEASE
Ion exchange resins of the Lewatit range for manufacturing of ultra pure water

LANXESS ion exchange resins applied in hydrogen production

April 15, 2024
PRESS RELEASE
LANXESS at InCosmetics 2023 in Barcelona

LANXESS presents extensive portfolio for the cosmetics industry

April 04, 2024
PRESS RELEASE
Adiprene Green

Sustainable, high performing systems and additives for the polyurethane industry

March 28, 2024